Dr. Nicholas Kartsonis Discusses the Many Contributions of Merck and Ongoing Research, and Treatments Addressing CDI
Join us on Tuesday, May 26th at 11a Pacific / 2p Eastern Time for an on-line live broadcast to learn about Merck's current treatments and research focused on C. diff infections by Dr. Nick Kartsonis, Associate Vice President of Clinical Research for Infectious Diseases for Merck Research Laboratories (MRL) and Section Head within MRL for antibiotics, antibacterials and cytomegalovirus voiceamerica.com/show/2441/c-diff-spores-and-more.
View full press release